Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nimodipine

EU orphan designation number: EU/3/15/1554   
Active ingredient: Nimodipine
Indication: Treatment of aneurysmal subarachnoid haemorrhage
Sponsor: Dr Stefan Blesse
Thierschstraße 3, D-80538 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/10/2015 Orphan designation EMA/OD/088/15 (2015)7025 of 09/10/2015